InsiderClue
Insiders · Profile

Espinoza Octavio

Chief Financial Officer at LIGAND PHARMACEUTICALS. Filing since 9 Nov 2022. CIK 0001905248

Company
Date
Role
Action
Shares
Amount
Of holding
LGND LIGAND PHARMACEUTICALS INC
12 Aug 2026
Chief Financial Officer
Sold on a plan
31,641
$9.24M
53.3%
LGND LIGAND PHARMACEUTICALS INC
11 Mar 2026
Chief Financial Officer
Sold on a plan
3,057
$687.83K
12.7%
LGND LIGAND PHARMACEUTICALS INC
4 Mar 2026
Chief Financial Officer
Sold on a plan
13,423
$2.76M
38.3%
LGND LIGAND PHARMACEUTICALS INC
12 Dec 2025
Chief Financial Officer
Sold at will
1,804
$339.71K
6.4%
LGND LIGAND PHARMACEUTICALS INC
9 May 2025
Chief Financial Officer
Bought
1,500
$156.09K
5.7%
LGND LIGAND PHARMACEUTICALS INC
4 Mar 2025
Chief Financial Officer
Sold at will
5,000
$575.15K
20.9%
LGND LIGAND PHARMACEUTICALS INC
23 Dec 2024
Chief Financial Officer
Sold at will
2,104
$244.85K
9.2%
LGND LIGAND PHARMACEUTICALS INC
20 Sep 2024
Chief Financial Officer
Sold at will
1,275
$132.52K
4.9%
LGND LIGAND PHARMACEUTICALS INC
17 May 2024
Chief Financial Officer
Sold at will
5,156
$446.84K
18.1%
LGND LIGAND PHARMACEUTICALS INC
16 May 2024
Chief Financial Officer
Sold at will
2,264
$194.71K
9.5%
LGND LIGAND PHARMACEUTICALS INC
15 May 2024
Chief Financial Officer
Sold at will
5,873
$505.15K
19.7%
LGND LIGAND PHARMACEUTICALS INC
28 Feb 2024
Chief Financial Officer
Sold at will
140
$12.38K
0.5%
LGND LIGAND PHARMACEUTICALS INC
9 Nov 2022
Chief Financial Officer
Sold, plan not stated
1,696
$128.28K
16.1%
13 decisions on file.